0001209191-21-019157.txt : 20210309 0001209191-21-019157.hdr.sgml : 20210309 20210309174008 ACCESSION NUMBER: 0001209191-21-019157 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210305 FILED AS OF DATE: 20210309 DATE AS OF CHANGE: 20210309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ho Tony W CENTRAL INDEX KEY: 0001713637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 21727124 MAIL ADDRESS: STREET 1: CRISPR THERAPEUTICS AG STREET 2: 610 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: BAARERSTRASSE 14 CITY: ZUG STATE: V8 ZIP: CH-6300 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-05 0 0001674416 CRISPR Therapeutics AG CRSP 0001713637 Ho Tony W C/O CRISPR THERAPEUTICS, INC. 610 MAIN STREET CAMBRIDGE MA 02139 0 1 0 0 Executive VP, Head of R&D Common Shares 2021-03-05 4 M 0 3333 A 37447 D Common Shares 2021-03-05 4 F 0 1585 114.65 D 35862 D On March 5, 2019, the reporting person was granted 10,000 restricted stock units. On March 5, 2021, 3,333 restricted stock units vested. Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Includes 150 shares acquired under the CRISPR Therapeutics AG 2016 Employee Stock Purchase Plan. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. /s/ Michael Esposito, attorney-in-fact 2021-03-09